Morgan Stanley raises United Therapeutics price target to $566
Morgan Stanley raised its price target on United Therapeutics to $566.00 per share from $515.00, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.